VI.REL PHARMA S.A.S Selects UMBRA GLOBAL

Share Article

UMBRA Global’s pvSafety has been selected by leading PcV Group

UMBRA Global’s pvSafety has been selected by VI.REL Pharma as their pharmacovigilance platform of choice.

Prof. Paolo Biffignandi, Executive Director says, “VI.REL is a well-known provider of pharmacovigilance services in Europe for many years and we selected pvSafety for its rich set of features, user-friendly interface and affordable pricing structure which allows us to comply with legal obligations on behalf of our clients."

pvSafety™ provides emerging pharma and biotech companies with the industry’s first “built for the Cloud” safety and pharmacovigilance membership solution. pvSafety™ is a full featured solution that has an aggressive pricing structure and comes with everything needed to switch from spreadsheets and paper to a fully electronic or hybrid pharmacovigilance system without the capital outlay and on-going costs. Infrastructure free pvSafety™ gives you control of your safety systems and many clients are up and running in less than a week, including validation, training and setup.

“With pvSafety we are disrupting an industry that has been slow to respond to the needs of life science companies. pvSafety opens the door to automation for thousands of small and medium pharmaceutical and biotech companies, as an affordable solution that is up and running in hours and where required validated in just days ”, says Ramon J. Dempers, CEO of UMBRA Global, LLC

About UMBRA Global: Based in Atlanta, GA, UMBRA Global is an innovative Health IT company providing a broad range of products and services to the Life and Health Science communities with a view to ensuring the health and wellbeing of people around the globe. UMBRA Global has an experienced and effective management team and superbly qualified advisory board that bring a wide range of skills and expertise to every engagement and client with whom they collaborate.

About VI.REL Pharma S.A.S
VI.REL Pharma is active as a consultancy in pharmacovigilance, medical writing and regulatory intelligence in the EU since 1997. Based in Italy, the company has strong relationships with international regulatory societies (e.g., TOPRA) and a strong clients’ portfolio across many European countries. A tailored approach to individual needs of SMEs has always been the winning strategy to offer affordable top-quality services with a personal involvement.

If you would like more information about this topic, please contact Sandra Moreland at 404-855-2654, email us at info@umbraglobal.com or visit our website at http://www.umbraglobal.com. # # #

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Sandra Moreland
UMBRA Global, LLC
+1 6782788284 Ext: 1
Email >
@UMBRAGlobal
since: 06/2014
Follow >
UMBRA Global
since: 06/2014
Like >
Umbra Global

Visit website